Von Willebrand Factor Human

CHEMBL4298126 Phase 4 Approved Unknown
Half-Life
Bioavailability
Protein Binding
Molecular Weight
g/mol
LogP
Phase
4

Human von Willebrand factor (VWF) is a large multimeric glycoprotein derived from plasma that mediates platelet adhesion to damaged subendothelium via interaction with collagen and platelet glycoprotein Ib-IX-V, and stabilizes and protects coagulation factor VIII from proteolytic degradation. Plasma-derived VWF concentrates are used for the treatment of von Willebrand disease (VWD) when desmopressin is insufficient, particularly for surgical prophylaxis and management of severe bleeding. VWF levels also influence risk in cardiovascular and pulmonary conditions.

Therapeutic Areas

Pharmacokinetics (PK)

Pharmacodynamics (PD)

HBD / HBA

- / -

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Frequently Asked Questions

Human von Willebrand factor (VWF) is a large multimeric glycoprotein derived from plasma that mediates platelet adhesion to damaged subendothelium via interaction with collagen and platelet glycoprotein Ib-IX-V, and stabilizes and protects coagulation factor VIII from proteolytic degradation. Plasma-derived VWF concentrates are used for the treatment of von Willebrand disease (VWD) when desmopressin is insufficient, particularly for surgical prophylaxis and management of severe bleeding. VWF levels also influence risk in cardiovascular and pulmonary conditions.

Yes, Von Willebrand Factor Human is an approved drug. It has reached clinical phase 4. It is classified as a Unknown.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL4298126. Open-access bioactivity database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-02-27.

Medical Disclaimer

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.